A model with differential susceptibility, differential infectivity (DS-DI), and age of infection is formulated in this paper. The susceptibles are divided into n groups according to their susceptibilities. The infectives are divided into m groups according to their infectivities. The total population size is assumed constant. Formula for the reproductive number is derived so that if the reproduction number is less than one, the infection-free equilibrium is locally stable, and unstable otherwise. Furthermore, if the reproductive number is less than one, the infection-free equilibrium is globally asymptotically stable. If the reproductive number is greater than one, it is shown that there exists a unique endemic equilibrium which is globally asymptotically stable. This result is obtained through a Lyapunov function.
Introduction
Genetic variability of susceptible individuals may lead to their differentiation in susceptibility to infection. Genetic predisposition of some individuals to some illnesses is well documented in the literature. For instance, tuberculosis is a centuries old disease of humans. Development of genetic tools have now given evidence that different individuals exhibit different susceptibility to the disease [1] . More recently, avian influenza H5N1 strains have started to infect humans mostly through bird-to-human transmission. However, limited human-to-human transmission also occurs primarily in families, suggesting possible genetic predisposition to the disease. Genetic evidence now exists that individuals may be exhibiting differential susceptibility to the infection, as well as subsequent different severity of the disease [2] . Host genetic factors play a major role in determining the susceptibility to infectious diseases. Further studies are needed to determine the hosts' differential susceptibility to various disease as well as its implications to public health. Here we develop a model that takes into account the differential susceptibilities (DS) of individuals.
In the study of HIV transmission, acute primary infection is followed by a chronic phase. During the chronic phase, HIV RNA levels drop several orders of magnitude and remain "nearly constant" for years [3, 4] , Viral levels differ by many orders of magnitude between individuals after the acute phase. People with high viral loads in the chronic phase tend to progress rapidly to AIDS, whereas those with very low loads tend to be slow or non-progressors [5, 6, 7] . To account for such differences between infected individuals, a differential infectivity (DI) SIR model was proposed in [8] , where the infected population is subdivided into n subgroups, I 1 , I 2 , · · · , I n . Differential infectivity is not unique only to HIV transmission. Viral levels, differing between individuals, have been shown in other diseases such as other sexually transmitted diseases, characterized by the so-called core groups [9, 10] , as well as malaria, and dengue fever, where the infectivity depends on parasite or viral loads in infected hosts or vectors [11, 12] .
In [13] , James M. Hyman and Jia Li, formulated compartmental differential susceptibility (DS) susceptible-infective-removed (SIR) models by dividing the susceptible population into multiple subgroups according to the susceptibility of individuals in each group. They derived an explicit formula for the reproductive number of infection for each model. They further proved that the infection-free equilibrium and endemic equilibria of each model were globally asymptotically stable. In [14] , Zhien Ma et al, presented several differential infectivity (DI) epidemic models under different assumptions. They established global stability of the infection-free equilibrium and the endemic equilibrium for DI models of SIR (susceptible/infected/removed) type with bilinear incidence and standard incidence but no disease-induced death. In [15] , James M. Hyman, and Jia Li, formulated differential susceptibility and differential infectivity models for disease transmission. They obtained explicit formulas for the reproductive number. They showed that the infection-free equilibrium is globally stable and there exists a unique endemic equilibrium for these models. In contrast with the above mentioned models, in this paper, we formulate a system of partial differential equations and perform global stability of equilibria.
To gain insight into the transmission dynamics of diseases with differential susceptibility and differential infectivity, the susceptibility and the infectivity are coupled and can not be separated. Results on couples' studies for HIV transmission suggest that differences may be due to variability in both susceptibility and infectivity. To further understand these phenomena, in this paper we propose a combined differential susceptibility and differential infectivity (DS-DI) epidemic model with age of infection, where recovered infectives are either completely removed or isolated, or they have full immunity after they recovery. The dynamics of the model are governed by a mixed system of ordinary differential equations and partial differential equations.
The model formulation
We consider the spread of a disease in a randomly mixing population that approaches a steady state S 0 , in the absence of infection. We assume that infected individuals who are removed from the population after they have recovered from infection, become fully immune. We approximate the transmission dynamics with an SIR (Susceptible → Infective → Recovered) model. We assume that susceptible individuals may have different susceptibilities and divide them into n groups, S 1 , S 2 , · · · , S n . Hence, the individuals in each group have homogeneous susceptibility, but the susceptibilities of individuals from different groups are distinct. The susceptibles are distributed into n susceptible subgroups based on their inherent susceptibilities. This is done in such a way that the input flow into group S k is p k µS 0 with n k=1 p k = 1. The infectives are divided into m groups i j (t, τ ), j = 1, · · · , m, which are assumed to be functions of age of infection τ . Each infective group is assumed to have different infectivity progression as a function of the time since infection. A susceptible individual in group S k enters an infectious group i j (t, τ ) with probability q kj and stays in this group until becoming recovered or removed. We must have m j=1 q kj = 1 for k = 1, · · · , n.
We assume full immunity of recovered individuals, or complete isolation after individuals are infected and diagnosed, and we group all these individuals in group R. The transmission dynamics of infection are governed by the following differential equations
where µ is the natural death rate in the absence of infection, and v j (τ ) is the age-sinceinfection dependent recovery or removal rate from group i j (t, τ ). The force of infection for the susceptibles in group S k is given by
where N denotes the total population size. The total population size is given by:
Model (2.1) is equipped with the following initial conditions:
The parameter α k gives the susceptibility of susceptible individuals in group S k , and β j (τ ) is the age-since-infection dependent infectivity in group i j (t, τ ). We denote by C B,U ([0, +∞), ) the set of bounded and uniformly continuous mappings from [0, +∞) to .
Summing the equations of (2.1), we have that the total population size N(t) satisfies the differential equation
whose solution is given by the formula
Therefore, we can assume the total population is constant, that is, N(t) = S 0 . Throughout this article we will work with the normalized system of system (2.1). We introduce the following fractions:
We note that the proportions do not exceed one for any value τ and t. The normalized force of infection is given by
We can rewrite system (2.1) as follows:
. Furthermore, we define
Define the linear operator
If λ ∈ C, with Reλ > −µ, then λ ∈ ρ(A j ), ρ(A j ) represents the resolvent set of A j , and we have the following explicit formula for the resolvent of A j ,
2) can be rewritten in the form of an ordinary differential equation as a non-densely defined Cauchy problem
where
and
Let A : D(A) ⊂ X → X be the linear operator defined by
, and then X 0 = D(A), and
With these definitions, we can rewrite system (2.2) as the following abstract Cauchy problem
The fact that the nonlinearities are Lipschitz continuous on bounded sets leads to the following proposition.
Lemma 2.2.([16])
There exists a uniquely determined semiflow {U(t)} t≥0 on X 0+ ,
, there exists a unique continuous map
To compute the projector on the eigenspace associated with the dominant eigenvalue, we now derive the linearized equations at the disease-free equilibrium. In addition, we study the uniform persistence of the system. The linearized equations at the disease-free equilibrium (s k f , 0 j , 0), k = 1, · · · , n, j = 1, · · · , m are given by:
Next we study the spectral properties of the linearized equations.
The essential growth bound
Here B X (0, 1) = {x ∈ X : x X ≤ 1}, and for each bounded set B ⊂ X, k(B) = inf{ε > 0 : B can be covered by a finite number of balls of radius ≤ ε} is the Kuratovsky measure of non-compactness.
The following Theorem shows the existence of a projector. The existence of a projector was first proved by Webb [20, 21] and the fact that there is a finite number of points of the spectrum has been proved by Engel and Nagel [22] . We denote by
Re(λ)).
Assume in addition that
is nonempty, finite and contains only poles of the resolvent of L. Moreover, there exists a finite rank bounded linear projector Π : X → X satisfying the following properties:
For the linearized system, the dynamics of i j do not depend on s k and r. In order to study the uniform persistence of the disease, we need to focus on the linear system
For λ ∈ C with Re(λ) > −µ, we defined the characteristic function ∆ j (λ) as
Then we have
Thus,
we note that
Then, we have:
Define the reproduction number
Assume that the reproduction number satisfies R 0 > 1. Then we can find λ 0 ∈ , such that
Furthermore, λ 0 > 0 is the dominant eigenvalue of A j + B j (see [20] ). Moreover, we have
Noticing that
and it satisfies
Thus, we have
The linear operator Π j : Y → Y is the projector onto the generalized eigenspace of A j + B j , associated with the eigenvalue λ 0 . We define Π :
We observe that the subset M 0 can be defined by
Volterra Formulation: Using Laplace transform arguments, one can establish that the mild solution of (2.2) takes the following form
The map b j (.) ∈ C([0, +∞), ) is the unique solution of the following Volterra integral equation
(2.5)
We substute (2.4) and (2.5) into the equations for s k (t) and r(t). According to [18] , we can discuss the limiting system associated with (2.2), k = 1, · · · , n, j = 1, · · · , m,
(2.6)
Stability of the infection-free equilibrium
In this section, we investigate the stability of the disease-free equilibrium. The stability of the disease-free equilibrium depends on the reproduction number R 0 . We show that the infection-free equilibrium is globally stable as long as R 0 < 1, and it is unstable if R 0 > 1. The process takes two steps. In the first step we prove the local stability of the infection-free equilibrium as well as its instability. In the second step we prove that the disease-free equilibrium is globally asymptotically stable, that is, we show that system (2.2) has a global attractor in ∂M 0 . System (2.6) always has the disease-free equilibrium
We linearize system (2.6) about E 0 by defining the perturbation variables s k (t) =
. We obtain the system
where x k0 , y j0 , and z 0 are to be determined. Substituting x k , y j and z into (3.1), we obtain the following equations
Theorem 3.1. The infection-free equilibrium E 0 is locally asymptotically stable if R 0 < 1, and it is unstable if R 0 > 1.
Proof. Considering the linearization of system (2.6) at the point E 0 , that is system (3.1), we letK
We get the following characteristic equation
D 3 is a n×m matrix, whose components are all 0.
Using mathematical induction, we can show that
Since L j > 0, j = 1, · · · , m, then it follows from M-matrix theory that each eigenvalue of |D 4 | is determined by 
Then (3.2) has a unique real solution λ * , which is a positive real number, if R 0 > 1. Let u = a + ib be a complex number, where i = √ −1, which is a solution of the characteristic equation (3.2) . Then by separating the real and the imaginary part of 
Hence, all solutions of (3.2) have negative real parts, if R 0 < 1. Therefore, the diseasefree equilibrium is locally asymptotically stable if R 0 < 1, and unstable otherwise. In addition, we can obtain the following theorem though straightforward analysis. Theorem 3.2. If R 0 < 1, the infection-free equilibrium E 0 is the unique attractor in ∂M 0 .
Proof: From the first equation of (2.6), it follows that
Therefore, considering the limsup as t → ∞ lim sup
Notice that
Hence,
We multiply both sides by ∞ 0 β j (τ )e −µτ B j (τ )dτ and sum to obtain:
(3.5) The coefficient on the right hand side of this inequality is exactly R 0 . Since we assume R 0 is strictly smaller than one, that is, R 0 < 1, the only way inequality (3.5) can hold is if lim sup
it is easy to show that lim sup t→∞ r(t) = 0. Hence, lim
This completes the proof of the theorem.
Existence and stability of the endemic equilibrium
In section 3 we have shown that if R 0 > 1, the infection-free equilibrium is unstable, and then the disease spreads when a small infection is introduced into the population. Now we assume R 0 > 1, and show that there exists an endemic equilibrium E * whose components are positive. Furthermore, we show that this endemic equilibrium is globally stable. For system (2.6), an endemic equilibrium needs to satisfy the equations
We set
Solving (4.1) for s k * and then for b j * and r * yields 
Define a function H(W ) by
Notice that, lim
where α = max{α 1 , . . . , α n }. Furthermore, H (W ) < 0.
Moreover, since H(0) = R 0 > 1, (4.4) has a unique positive solution W * . Substituting W * into (4.3), we have that system (2.6) has a unique positive endemic equilibrium E * . We summarize this result in the following theorem.
Theorem 4.1. There exists a unique positive equilibrium E * if R 0 > 1. In the remainder of this section we assume that R 0 > 1, and we discuss the persistence of the system and the global stability of the endemic equilibrium E * .
Lemma 4.2.( [19] ) Let X be locally compact, let X 2 be compact in X and X 1 be forward invariant under the continuous semiflow Φ on X. Assume that
Proof. We recall that R 0 > 1. Let δ > 0 and n ∈ (0, p k ) with n ∈ + satisfy n → 0 as n → ∞. We argue by contradiction. Assume that for each n ≥ 0, we can
and we have |s
Thus, the following inequality holds:
Applying the Laplace transform to both sides of that inequality, we obtain
whereû denotes the Laplace transform of u, and λ > 0. Multiplying both sides by ∞ 0 β j (τ )B j (τ )e −(µ+λ)τ dτ and summing by j, we obtain the following inequality:
For n = 0 and λ = 0, the quantity in the parentheses is exactly the reproduction number R 0 . Since R 0 > 1, for n > 0 and λ > 0 but both small enough, this quantity is still larger than one, that is
which is a contradiction. Moreover, there exists A 0 , a compact subset of M 0 , which is a global attractor for U(t) t≥0 in M 0 . Proof. Since the disease free equilibrium E 0 is globally asymptotically stable in ∂M 0 , then the solutions of system (2.2) that start in ∂M 0 are far from E 0 as t → −∞. In addition, E 0 = x f is ejective in M 0 for {U(t)} t≥0 when R 0 > 1. The result on persistence follows from Lemma 4.2 and Proposition 4.3. This completes the proof of persistence.
In what follows, we discuss the global stability of the endemic equilibrium in A 0 . Firstly, by using the Volterra's formulation of system (2.2), we obtain that
From Proposition 4.4, we get the following lemma Lemma 4.5. There exist constants H > ε > 0, such that for every complete orbit of system (2.2) in an invariant set, we have 
Then,
)dτ, where
)ds, (4.8) and thus dV
Moreover, by the definition of Θ k we have
)dτ. 
Substituting the expression of the function f , we obtain
Then, by combining (4.7) and (4.12) we have
]dτ.
(4.13)
The objective now is to show that dV dt is non-positive. In order to obtain this, we demonstrate that two of the terms above cancel out
We may multiply both sides of
(4.14)
Using this expression to simplify equation (4.13), one gets
(4.15)
is independent of τ , we may multiply both sides of (4.14) by this quantity to obtain
In addition, multiplying both sides of (4.16) by α k and summing for k from 1 to n, we may obtain
We now add (4.17) to (4.15), and also add and subtract ln(
where for all τ ≥ 0.
To complete the proof, we look for the largest invariant set M for which (4.16) holds.
In M, we must have s k (t) = s k e for all t and so we also have Remark 4.7. The endemic equilibrium is global asymptotically stable when m ≤ n which is determined by the construction of Lyapunov function V . If m > n, the stability of the endemic equilibrium remains an open problem.
Discussion
In this article we have formulated compartmental differential susceptibility and differential infectivity models in various settings. The susceptibles and infectives are respectively divided into n and m subgroups based on their susceptibilities and infectivies. We consider the case where the total population size is constant. We study the transmission dynamics of the infection based on a variety of differential susceptibility and differential infectivity models. As typical in classical epidemiological models, there are two types of equilibria in our models. We derive an explicit formula for the reproductive number, R 0 . For the model with standard incidence, we show that the infection-free equilibrium, whose component of infectives is zero, is globally asymptotically stable if R 0 < 1. If R 0 > 1, we further prove that there exists a unique endemic equilibrium with all components positive. Using a Lyapunov function on an invariant set, we further prove the global stability of the endemic equilibrium in the case m ≤ n. The case m > n remains an open problem.
Recent mathematical epidemiology studies suggest that multiple endemic equilibria may exist and Hopf bifurcation may lead to periodicity for some endemic models [23] . Multi-strain transmission [24] may exhibit backward bifurcation and competitive exclusion. Our study, nevertheless, excludes such phenomena for the DS-DI epidemic models formulated in this paper. Our contribution here lies in extending the mathematical techniques for deriving global behavior of multigroup models structured by age-since-infection.
